Neuropeptides like galanin produced and released by small cell lung cancer (SCLC) cells are considered principal mitogens in these tumors. We identi®ed the galanin receptor type 2 (GALR2) as the only galanin receptor expressed in H69 and H510 cells. Photoanity labeling of G proteins in H69 cell membranes revealed that GALR2 activates G proteins of three subfamilies: G q , G i , and G 12 . In H69 cells, galanin-induced Ca 2+ mobilization was pertussis toxin-insensitive. While phorbol ester-induced extracellular signal-regulated kinase (ERK) activation required protein kinase C (PKC) activity, preincubation of H69 cells with the PKCinhibitor GF109203X had no eect on galanin-dependent ERK activity. A rise of the intracellular calcium concentration was necessary and sucient to mediate galanin-induced ERK activation. In support of G i coupling, stimulation of GALR2 expressed in HEK293 cells inhibited isoproterenol-induced cAMP accumulation and raised cAMP levels in COS-7 cells when coexpressed with a chimeric Ga S -Ga i protein. In H69 cells, galanin activated the monomeric GTPase RhoA and induced stress ®ber formation in Swiss 3T3 cells expressing GALR2. Thus, we provide the ®rst direct evidence that in SCLC the mitogenic neuropeptide galanin, interacting with GALR2, simultaneously activates multiple classes of G proteins and signals through the G q phospholipase C/calcium sequence and a G 12 /Rho pathway. Oncogene (2000) 19, 4199 ± 4209.
Introduction
Approximately 25% of all primary carcinomas of the lung are classi®ed histologically as small cell lung cancer (SCLC), a subtype which is characterized by rapid growth and a high metastatic potential, giving rise to a 5-year survival rate of only 5% despite initial radio-and chemosensitivity (Lassen et al., 1995) . Therefore, considerable eort is currently being devoted to the design of novel therapeutic approaches, which are based on an advanced understanding of the tumor biology of SCLC. In contrast to non-SCLC, transforming Ras mutations or overexpression of receptor tyrosine kinases are usually not encountered in SCLC, and the expression of GTPase-de®cient Ras mutants or of a constitutively active Raf kinase induces growth arrest and apoptosis Ravi et al., 1998) . These ®ndings lend credibility to the belief that the main driving force for growth and proliferation of this subtype of cancer is represented by various neuropeptides, e.g. bombesin/gastrin-releasing peptide (GRP), bradykinin, cholecystokinin, gastrin, neurotensin, vasopressin and galanin which stimulate SCLC cells via multiple auto-and paracrine loops (Rozengurt, 1999) . Consequently, neuropeptide-induced signal transduction pathways have attracted considerable attention as they may provide potential targets for novel therapeutic strategies aimed at interfering with growth stimulatory autocrine loops. Many neuropeptides and their corresponding cell surface receptors are expressed in SCLC cells (Bepler et al., 1988; Moody et al., 1985) . Various SCLC cell lines, like H69 and H510, are generally employed as suitable in vitro models to study the molecular mechanisms of the mitogenic activity of neuropeptides in SCLC.
Neuropeptides exert their cellular eects by binding to G-protein-coupled receptors (GPCRs), a large and diverse superfamily of proteins characterized by a seven-transmembrane structure (Gudermann et al., 1997; SchoÈ neberg et al., 1999; Strader et al., 1994) . Agonist-bound neuropeptide receptors transmit information into the cell by activating regulatory guanine nucleotide-binding proteins (G proteins) composed of a, b, and g subunits. G proteins are classi®ed based upon primary sequence similarity of their a subunits and are subdivided into four families: G s , G i , G q , G 12 (Simon et al., 1991) . Receptor activation initiates the exchange of GDP for GTP in the G-protein a subunit followed by dissociation of the G-protein heterotrimer into a GTP-bound a subunit and a bg dimer. Both, Ga-GTP and Gbg are signaling molecules in their own right and activate a diverse array of eector systems such as enzymes and ion channels (Birnbaumer et al., 1990; Clapham and Neer, 1997; Gautam et al., 1998; Hepler and Gilman, 1992) . In recent years it has become evident that receptor/G protein systems play an important role in cell dierentiation, proliferation and even in transformation by engaging signal transduction pathways like MAPK cascades which are classically employed by growth factors such as EGF or PDGF (Dhanasekaran et al., , 1998 Gutkind, 1998; van Biesen et al., 1996) . In addition, GTPase-de®cient G-protein a subunits can induce a transformed phenotype in certain ®broblast cell lines, and mutationally activated G-protein a subunits have been identi®ed in human tumors (Dhanasekaran et al., , 1998 .
The neuropeptide galanin was among the ®rst peptide growth factors for which a mitogenic eect on SCLC cells was demonstrated (Sethi et al., 1992; Sethi and Rozengurt, 1991a,b) . Galanin is a 29-amino acid (30 in men) polypeptide which is abundantly expressed in brain as well as in peripheral tissues. The regulation of a variety of physiological processes like stimulation of food intake, nociception, memory, depression, and control of neuroendocrine hypothalamic-pituitary circuits has been correlated with galanin and its receptors (Bartfai et al., 1993; Bedecs et al., 1995; Kask et al., 1995; Wang and Gustafson, 1998) . In pituitary GH 3 cells and in the pancreatic b-cell model RINm5F, galanin interferes with hormone release by inhibition of voltage-gated Ca 2+ channels (Kalkbrenner et al., 1995) . In H69 and H510 SCLC cells, galanin challenge does not aect the membrane potential but causes a rapid and transient rise of the intracellular Ca 2+ concentration [Ca 2+ ] i in a pertussis toxin-insensitive manner and stimulates the clonal growth of SCLC cells in semisolid medium (Sethi and Rozengurt, 1991a) . The growth-stimulatory eect of galanin on SCLC cells is mediated by the ERK subfamily of mitogen-activated protein kinases (MAPKs), which are activated by galanin in a PKCdependent fashion (Seuerlein and Rozengurt, 1996) .
The fact that galanin initiates an entirely dierent set of early events in SCLC cells as compared to pituitary or pancreatic endocrine cells, supports the hypothesis that galanin receptors expressed in SCLC cells are distinct from those mediating the inhibitory eects on neurotransmission and secretion in neuronal and endocrine cells, respectively. As yet, three galanin receptor subtypes, denoted GALR1, GALR2, and GALR3, have been cloned which dier in their ligand binding and signal transduction characteristics (Wang and Gustafson, 1998) . So far, the molecular identity and the G-protein coupling pro®le of the galanin receptor expressed in SCLC cells remain elusive.
In the present study, we show that GALR2 is the only galanin receptor subtype expressed in SCLC cells. For the ®rst time, direct evidence is presented that in SCLC cells as well as in several heterologous cell systems GALR2 couples to members of three Gprotein sub-families, i.e. G q , G i and G 12 . In SCLC cells, activation of G q/11 proteins results in elevated [Ca 2+ ] i sucient to stimulate ERK activity even in the absence of PKC activity. In the same tumor cell model, galanin stimulation results in activation of the monomeric GTPase Rho most likely via G 12/13 . As Rho proteins are able to profoundly modify the growth properties of SCLC cells (Tokman et al., 1997) , our results add to a deeper understanding of SCLC tumor biology and may highlight novel therapeutic targets.
Results

Expression of galanin receptor subtypes in H69 and H510 cells
Galanin has been shown to stimulate the clonal growth of H69 and H510 SCLC cells (Sethi and Rozengurt, 1991a) . In order to determine which galanin receptor subtypes, GALR1, GALR2 or GALR3, are expressed in these cells, total RNA from H69 and H510 cells was isolated, and a reverse transcription polymerase chain reaction was performed. Ampli®cation products of the expected size were obtained only with primers speci®c for the GALR2 (Figure 1, lanes 4 and 5) . The primer combinations used were tested by amplifying the corresponding receptor fragments using a human brain library (Superscript cDNA library, Gibco ± BRL) as a template (data not shown), and the identity of the PCR products was con®rmed by direct DNA sequencing. In the two tumor cell lines examined, neither GALR1 nor GALR3 were detected (Figure 1 , lanes 1, 2 and 7, 8 respectively) suggesting that galanin-mediated eects in these SCLC cells are exclusively mediated by GALR2.
Photoaffinity labeling of galanin-activated G-proteins in H69 cells
To identify the G proteins which couple to the agonistbound GALR2 in H69 cells, we resorted to the approach of photoanity labeling of receptor-activated G-proteins in conjunction with selective immunoprecipitation of radioactively labeled G-protein a subunits . Membranes of H69 cells were incubated with or without 1 mM galanin in the presence of the non-hydrolysable GTP-analog [a-32 P]GTP azidoanilide. After UV cross-linking of the photolabel, Gprotein a subunits were immunoprecipitated by speci®c antisera, resolved on SDS polyacrylamide gels and visualized by autoradiography. As shown in Figure 2a , treatment of H69 cell membranes with galanin resulted in increased incorporation of radioactivity into Ga q/11 proteins. In addition, galanin challenge of H69 membranes caused signi®cant labeling of Ga 12 , minor [a-32 P]GTP azidoanilide binding to Ga 13 and small but reproducible agonist-induced photo anity labeling of Ga i . The reduced incorporation of radioactivity into Ga 13 as compared to Ga 12 proteins cannot be simply explained by reduced Ga 13 protein expression in H69 membranes, since both, Ga 12 and Ga 13 , were clearly detectable by immunoblotting (Figure 2b ). Likewise, in the same membrane preparation Ga s , Ga q/11 , and Ga i Figure 1 GALR2 expression in SCLC cell lines H69 and H510. Reverse transcription polymerase chain reaction (RT ± PCR) experiments were performed with total RNA from H69 cells (lanes 1, 4, 7), H510 cells (lanes 2, 5, 8), or as negative control water (lanes 3, 6, 9) using receptor subtype-speci®c primers as indicated. Aliquots of the RT-PCR mixture were separated on a 1% agarose gel, and ampli®cation products were visualized by ethidium bromide staining. DNA size standards (100-bp ladder) are shown (M) as base pairs (bp) on the right proteins were visible as 52/44, 42, and 40 kDa proteins, respectively (see Figure 2b) .
To be able to characterize the signal transduction properties of GALR2 in more detail, we isolated the GALR2 cDNA from H69 cells employing the RACE technique (rapid ampli®cation of cDNA ends) as described in the Materials and methods section. The cloned GALR2 cDNA sequence was identical to the one recently isolated from human small intestine (Bloomquist et al., 1998) .
In order to see how the G-protein coupling pro®le of GALR2 in H69 cells would compare to that in a dierent cellular background, we transiently expressed the recombinant human GALR2 in COS-7 cells and performed photoanity labeling experiments with cell membranes. In essence, we obtained the same results as for H69 cell membranes except for the lack of GALR2-dependent G 13 activation in COS-7 cells (Figure 2c ). Collectively, these results directly demonstrate that the GALR2 endogenously expressed in H69 cells as well as heterologously expressed in COS-7 cells has the ability to activate G-proteins of the G q , G i , and G 12 families. To further assess the biological relevance of our Gprotein coupling data, we set out to analyse signal transduction pathways speci®c for individual G-protein families activated by GALR2 in H69 cells as well as in several other cell systems. (Figure 3a) . Thereafter, [Ca 2+ ] i slowly declined but exceeded unstimulated basal levels throughout the observation period of 3 min after the galanin stimulus. Pretreatment of cells with pertussis toxin (100 ng/ml for 20 h) prior to the stimulation with galanin had no inhibitory eect at all, demonstrating an exclusive involvement of pertussis toxin-insensitive G-proteins in galanin-induced Ca 2+ transients ( Figure 3b ). For the most part, the observed increase in [Ca 2+ ] i resulted from Ca 2+ release from internal stores, since chelating of extracellular Ca 2+ by EGTA (®nal concentration in the cuvette: 3.9 mM) prior to stimulation with galanin did not diminish galanin-dependent Ca 2+ rises in H69 cells (data not shown). In conclusion, these results Figure 2 Photoanity labeling of G-protein a subunits in H69 and COS-7 cell membranes. Aliquots of H69 (a) or COS-7 (c) cell membranes (100 mg for Ga q/11 , Ga i ; 150 mg for Ga 12 , Ga 13 ) were incubated with the photoreactive [a 32 P]GTP azidoanilide in the absence or presence of galanin (7/+) for 3 ± 30 min depending on the G protein studied (see Materials and methods) and UVirradiated for 15 s. Photolabeled G-protein a subunits were immunoprecipitated with appropriate antibodies, subjected to SDS ± PAGE and visualized by autoradiography or phosphoimaging. Representative autoradiographs out of at least three independent experiments with two dierent membrane preparations are shown. (b) Membrane proteins of H69 cells (50 mg per lane) were resolved on 10% SDS polyacrylamide gels and subsequently blotted onto nitrocellulose. Membranes were cut into strips and incubated with antisera against Ga subunits as indicated. Positions of the 42 kD molecular weight marker protein are shown on the left can be explained by coupling of GALR2 to G q/11 proteins in H69 SCLC cells (see Figure 2a ).
Activation of extracellular signal-regulated kinases
The neuropeptide-induced activation of ERK-MAP kinases is an essential component of mitogenic signals arising from the agonist-bound galanin receptor in SCLC cells (Seuerlein and Rozengurt, 1996) . Therefore, we set out to further dissect the signaling pathways underlying the ability of galanin to stimulate ERK activity in H69 cells. Treatment of H69 cells with galanin led to a moderate (1.55+0.19-fold) stimulation of ERK activity ( Figure 4 ). The stimulatory eect of galanin was nearly abolished by pretreatment of cells with 1 mM staurosporine, indicating participation of serine/threonine kinases, e.g. PKC isozymes, in galanin-induced ERK activation. However, a 30-min pretreatment of H69 cells with the speci®c PKC inhibitor bisindolylmaleimide I (GF109203X) at 1 mM had no eect on galanin-induced ERK activation (see Figure 4 ). At the same time, preincubation of H69 cells with the same batch and concentration of GF109203X for 30 min caused an almost complete inhibition of phorbol-12-myristate-13-acetate (PMA)-induced activation of ERK ( Figure 4 , inset) demonstrating that the protein kinase C inhibitor used was biologically active and could inhibit PKC-dependent ERK activity in these cells. These results would indicate that phorbol ester-stimulated PKC activity is sucient to cause ERK activation in SCLC cells, but that PKC activity is not necessary for galanin to signal to ERK in H69 cells. Therefore, galanin-dependent ERK activation can proceed through alternative pathways independent of PKC. SCLC exhibits neuroendocrine features and is characterized by the presence of cytoplasmic neurosecretory granules. In neuroendocrine PC12 cells, Ca 2+ transients alone are sucient to trigger ERK activation (Rosen et al., 1994 ). Therefore, we tested whether an increase in [Ca 2+ ] i would suce to stimulate ERK activity in H69 cells. Treatment of SCLC cells with the calcium ionophore ionomycin (1 mM) caused an increase in ERK activity (1.47+0.2-fold) comparable with that observed after stimulation with galanin (see Figure 4 ). When Ca 2+ transients were precluded by preincubation of cells with the cell permeable Ca 2+ chelator BAPTA, galanin-mediated ERK activity was abrogated (1.08+0.13-fold). Collectively, these data show that a galanin-mediated elevation of [Ca 2+ ] i alone is sucient to mediate ERK activation in H69 cells.
Effect of GALR2-activation on cAMP formation and inositol phosphate accumulation
The majority of G-protein-coupled receptors has the ability to couple to more than one G protein . Signaling pathways linking G-protein-coupled receptors to ERKs can only be dissected meaningfully if the G protein coupled by the receptors and the functional relevance of each receptor/ G-protein interaction is known. To study whether coupling of GALR2 to G q/11 and to G i proteins in H69 cell membranes as determined by photoanity labeling of receptor-activated G-proteins (see Figure 2 ) is mirrored by the engagement of typical G q/11 -and G imediated signal transduction pathways, we transiently expressed the GALR2 in COS-7 cells, a frequently employed cellular model, and analysed its signaling properties. In transfected COS-7 cells, galanin stimulation resulted in a concentration-dependent increase in the production of inositol phosphates with an EC 50 value of 22+9 nM ( Figure 5a ). Inositol phosphate accumulation was pertussis toxin-insensitive (data not shown) and most likely re¯ected G q/11 -mediated activation of phospholipase C-b isoforms.
Next we analysed G i -mediated coupling of GALR2 to adenylyl cyclase by coexpressing GALR2 with Ga s-i5 , a chimeric G-protein a subunit in which the C-terminal 5 amino acids of Ga s are replaced by the corresponding amino acids of Ga i2 . This G-protein chimera has been shown to eciently redirect signaling of G i -coupled receptors from inhibition to stimulation of adenylyl cyclase (Komatsuzaki et al., 1997) . In cells transiently transfected with GALR2 cDNA, galaninstimulated cAMP formation did not dier from basal levels, exemplifying the inability of GALR2 to interact with G s proteins (Figure 5b) . Similarly, despite moderately elevated basal cAMP levels in cells transiently transfected with Ga si-5 cDNA alone, galanin did not promote agonist-induced cAMP formation (see Figure 5b ). However, galanin-dependent cAMP formation was clearly discernable in COS-7 cells cotransfected with GALR2 and Ga s-i5 cDNA additionally proving the capability of GALR2 coupling to Gproteins of the G i class (see Figure 5b) .
In a second approach we assessed the ability of the GALR2 to inhibit cAMP formation in HEK293 cells. Galanin-stimulated ERK activation in H69 cells requires elevation of intracellular calcium. Aliquots of H69 cells (3610 6 cells) were stimulated with 1 mM ionomycin or pretreated with staurosporine (1 mM, 30 min), GF109203X (1 mM, 30 min), or BAPTA-AM (1 mM, 30 min) and subsequently stimulated with 100 nM galanin for 5 min as indicated. ERK1/2 were immunoprecipitated, and immune complex kinase assays were performed as described in Materials and methods. The data are presented as means+s.d. of at least three independent experiments performed in duplicate and are expressed as -fold stimulation relative to mean basal ERK activity. Inset. Aliquots of H69 cells (3610 6 cells) were pretreated with GF109203X (1 mM, 30 min) and stimulated with 1 mM phorbol-12-myristate-13-acetate (PMA) for 5 min. Control cells were treated with solvent (DMSO). ERK activity was determined as described in Materials and methods, and data are presented as counts per minute (c.p.m.)+R of one representative experiment out of two performed in duplicate In the latter cells, G i -mediated inhibition of adenylyl cyclase is not confounded by the simultaneous activation of a Gbg-stimulable adenylyl cyclase like in COS cells (Wong, 1994) . Thus, GALR2 was transiently coexpressed with the human b 2 -adrenoceptor (b 2 AR), and cAMP formation was stimulated via the b 2 AR receptor by incubation of the cells with 10 mM isoproterenol. Under these conditions addition of 1 mM galanin inhibited cAMP formation by 25.5+9.7% ( Figure 5c ). As a positive control, we coexpressed the b 2 AR with the G i -coupled M 2 muscarinic acetylcholine receptor instead of GALR2. In this case, isoproterenol-stimulated cAMP formation was suppressed by 67+6.1% following the addition of 100 mM carbachol (see Figure 5c ). In summary, these ®ndings in COS-7 and HEK293 cells are in line with the results of our photolabel experiments in H69 SCLC cells (see Figure 2 ) and show that coupling of GALR2 to G q/11 and G i proteins engages corresponding classical signal transduction pathways in dierent cell systems.
Rho activation and actin stress fiber formation mediated by GALR2
Photoanity labeling experiments with H69 and COS-7 cell membranes revealed an interaction between GALR2 and G 12 proteins. G 12/13 proteins have been suggested to link G-protein-coupled receptors to the monomeric GTPase Rho and to reorganization of the actin cytoskeleton (Buhl et al., 1995) . To see whether galanin challenge of SCLC cells would lead to activation of Rho GTPases, we used a GST-ROKa fusion protein (Kranenburg et al., 1999) as a bait for GTP-loaded RhoA. H69 and H510 cells were incubated either with galanin or as a positive control with lysophosphatidic acid (LPA), which is known to regulate the assembly of stress ®bers and focal adhesions via RhoA (Ridley and Hall, 1992) . GTPloaded RhoA bound to GST-ROKa was detected in cell lysates with a monoclonal anti-RhoA antibody and quanti®ed by ELISA. In H69 and H510 cells galanin stimulation resulted in a moderate increase in the GTPloaded fraction of the monomeric GTPase ( Figure  6a,b) . The magnitude in the increase of Rho-GTP binding to GST-ROKa was comparable for galanin and LPA stimulation of SCLC cells. Immunoblot analysis of a portion of SCLC cell lysates used in the ELISAs con®rmed the expression of RhoA in both cell lines (Figure 6c ).
To unequivocally show that activation of RhoA was due to stimulation of GALR2, we examined galanindependent stress ®ber formation in Swiss 3T3 ®bro-blasts which are a well characterized cellular model system to study agonist-induced and Rho-dependent stress ®ber formation. These cells do not express endogenous galanin receptors, and thus the human GALR2 was expressed in quiescent, serum-starved Swiss 3T3 cells by means of intranuclear injection of cDNA. Stimulation of microinjected Swiss 3T3 cells with 100 nM galanin led to formation of actin stress ®bers within 15 min (Figure 7a ). Galanin-induced stress ®ber formation critically depended on the expression of functionally intact galanin receptors, because neuropeptide-induced cytoskeletal rearrangements were abrogated when a GALR2 deletion mutant designated GALR2-D218 ± 230 was expressed instead of wild-type GALR2 (Figure 7b ). In this deletion mutant, 13 amino acids within the third intracellular loop were deleted, rendering the receptor incapable of G-protein interaction (data not shown). To aid identi®cation of microinjected cells, dextran-conjugated texas red was coinjected with the receptor cDNAs (Figure 7c,d ).
Discussion
Neuropeptides produced and released by SCLC cells are regarded as the principal mitogens in these tumors Rozengurt, 1999) . Galanin was among the ®rst Ca 2+ mobilizing peptides for which a mitogenic eect on SCLC cells was clearly demonstrated (Sethi and Rozengurt, 1991a) . Early signaling events initiated by galanin in SCLC cells are notably disparate from those induced by the same agonist in pituitary, pancreatic, and other neuronal cells (Kalkbrenner et al., 1995; Sethi and Rozengurt, 1991b; Seuerlein and Rozengurt, 1996; Wang & Gustafson, 1998) . These observations either re¯ect a cell-typespeci®c expression of crucial signaling proteins or indicate that the galanin receptors mediating clonal growth in SCLC cells are molecular entities separate from those responsible for galanin-induced Ca 2+ channel inhibition. However, the issue concerning the molecular identity of galanin receptors expressed in SCLC cells remained unresolved.
Molecular cloning eorts in the past few years revealed that there are at least three genes coding for heptahelical receptors, which bind galanin with high anity (Wang and Gustafson, 1998) . GALR1 is most abundantly expressed in brain and in the spinal cord and is a classical G i -coupled receptor (Habert-Ortoli et al., 1994) . GALR2 is more widely distributed in peripheral tissues and to a lesser extent in the central nervous system (Wang and Gustafson, 1998) . Most authors describe the receptor's ability to activate phospholipase C-b in a pertussis toxin-insensitive manner, representing indirect evidence for coupling to G q proteins (Pang et al., 1998; Smith et al., 1997; . GALR3 is prominently expressed in spleen, heart and testis as well as in several regions of Figure 7 Stimulation of GALR2 causes the reorganization of the actin cytoskeleton in Swiss 3T3 ®broblasts. Swiss 3T3 cells were cultured on glass coverslips, serum-starved and microinjected with expression plasmids coding either for GALR2 (a) or the functionally inactive receptor mutant GALR2D218-230 (b). Cells were further incubated for 24 h, subsequently treated with galanin (100 nM) for 15 min, and ®xed in paraformaldehyde. The actin cytoskeleton was stained with FITC-phalloidin and visualized on an inverted microscope at a 400-fold magni®cation Figure 6 RhoA activation by galanin and LPA in SCLC cells. Aliquots of H69 (a) or H510 (b) cells (2610 6 cells) were cultured in HITESA medium for 3 days. Stimulations with vehicle (basal), 100 nM galanin or 10 mM LPA were carried out at 378C for 5 min and reactions were stopped on ice. Cells were collected by centrifugation and subsequently lysed at 08C. Lysates were cleared by centrifugation and added to anti-GST/GST-ROKa precoated 96-well plates. GTP-RhoA binding to GST-ROKa was quantitatively determined by applying an ELISA technique (see Materials and methods). Data are represented as means+s.e.m. of three independent experiments performed in quadruplicate. (c) Expression of RhoA in lysates of H510 (lanes 1 ± 3) or H69 cells (lanes 4 ± 6) was con®rmed by SDS ± PAGE and immunoblotting using a monoclonal anti-RhoA antibody the brain (Smith et al., 1998; Wang et al., 1997b) . Functional data on GALR3 are scant; yet coexpression of the receptor with GIRK1 and GIRK4 potassium channels resulted in inward K + currents providing ®rst evidence for GALR3 being a G i -coupled receptor (Smith et al., 1998) .
In the present study we demonstrate that the mitogenic eects of galanin on SCLC cells are mediated by a single galanin receptor subtype, GALR2. In accord with earlier studies (Sethi et al., 1992; Sethi and Rozengurt, 1991a,b) we observed that galanin evokes a pertussis toxin-insensitive Ca 2+ mobilization in H69 cells, but in addition we directly show galanin-dependent activation of G q/11 proteins in SCLC cell membranes. Per de®nition, receptor-catalyzed GDP/GTP exchange is the only direct measure to monitor G-protein activation, while second messenger studies alone only yield circumstantial evidence. Therefore, the experimental approach that was chosen to monitor GALR2/G-protein interaction consisted of a combination of receptor-dependent photolabeling of G-protein a subunits with subsequent immunoprecipitation. This experimental design has previously been adopted for the signaling analysis of various G-proteincoupled receptors (Allgeier et al., 1994; Herrlich et al., 1996; KuÈ hn et al., 1996; Laugwitz et al., 1994) . Photolabeling experiments employing the non-hydrolyzable GTP analog [a-32 P]GTP azidoanilide showed that in membranes of H69 cells as well as in COS-7 cells, GALR2 couples to G 12 and to a lesser extent to G i proteins apart from interacting with G q/11 . Thus, GALR2 has to be added to the ever growing list of heptahelical receptors with multiple G-protein coupling potential (Gudermann et al., , 1997 . Two other G-protein-coupled receptors involved in the regulation of cell growth and dierentiation, the thrombin receptor and the neurokinin-1 receptor, are characterized by the same broad G-protein coupling pattern (Barr et al., 1997; Oermanns et al., 1994) . However, to our knowledge the present study is the ®rst to directly demonstrate the activation of members of three distinct G-protein families, i.e. G q , G 12 , and G i , by a endogenously expressed neuropeptide receptor.
We further analysed classical cellular signal transduction pathways initiated by the dierent G-proteins activated by GALR2. While most authors agree on the receptor's ability to couple to phospholipase C-b isoforms via G q/11 proteins, the additional interaction of GALR2 with G i or G o is discussed controversially (Pang et al., 1998; Smith et al., 1997; Wang et al., 1997a . The galanin-induced inhibition of isoproterenoldependent cAMP accumulation in HEK293 cells coexpressing the human b 2 AR and GALR2 is considerably smaller than the eect of carbachol acting on the M 2 muscarinic receptor. This eect is compatible with the fairly modest activation of G i proteins via GALR2 as assessed by photoanity labeling experiments in H69 cell membranes and can therefore be regarded as a true re¯ection of the G i coupling eectiveness of GALR2 in an intact cell setting.
Mutagenesis studies have shown that the C-terminus of G protein a subunits plays a pivotal role in de®ning the speci®city of receptor/G-protein interaction (Liu et al., 1995) . In particular, the C-terminal 5 amino acids are sucient to switch the receptor speci®city of Ga q / Ga i2 chimeric proteins. Therefore, we took advantage of the chimeric G-protein a subunit G s-i5 characterized by the replacement of the C-terminal ®ve amino acids of G s by the corresponding amino acids of G i2 , thus enabling a G i -activating receptor to stimulate adenylyl cyclase (Komatsuzaki et al., 1997) . Transient expression in COS-7 cells of human GALR2 in conjunction with G s-i5 conferred the ability upon the agonist-bound receptor to initiate intracellular cAMP production. These data provide independent experimental evidence for the G i -coupling potential of GALR2. So far, the role of GALR2/G i interaction in galanin-mediated mitogenic signaling remains elusive. However, the failure of pertussis toxin to appreciably inhibit in vitro growth of SCLC cells (Viallet et al., 1990) indicates that pertussis toxin-sensitive G i proteins are unlikely to play a pivotal role.
The growth of SCLC cells critically depends on neuropeptide receptor/G q/11 -initiated phospholipase C (Beekman et al., 1998) and ERK activity (Seuerlein and Rozengurt, 1996) . PKC isotypes are central signaling molecules coupling the pertussis toxininsensitive G q/11 family of G-proteins to ERKs. While down-regulation of PKC-isoforms by phorbol ester pretreatment abrogated galanin-and phorbol esterinduced ERK activation in H69 and H510 cells (Seuerlein and Rozengurt, 1996) , in our hands the speci®c PKC inhibitor bisindolylmaleimide I only inhibited phorbol ester-induced ERK activity, but the galanin eect remained unaltered in H69 cells. In fact, we found that a rise of Ca 2+ , the other second messenger originating from phospholipase C activity, was sucient to stimulate ERK activity in SCLC cells. Thus, it appears that in H69 cells signals from G qcoupled receptors to ERK can follow two independent routes, the one depending on PKC activity, the other relying on Ca
2+
. In CHO cells ERK activation via primarily G q/11 -coupled receptors has been reported to involve G o proteins (van Biesen et al., 1996; , while in most other cell systems G q/11 -coupled receptor signal to ERK in a strictly G q/11 /phospholipase C-bdependent manner (Grosse et al., 2000a,b) . As G o proteins are not expressed in most other ®broblast cell lines used to express recombinant G-protein-coupled receptors, the CHO cell model represents a rare exception rather than the rule, but nevertheless illustrates that signaling pathways can be aected by the cellular background. Thus, G-protein-coupling studies on GALR2 expressed heterologously have to be supplemented by experiments on GALR2 endogenously expressed in a native environment, e.g. SCLC cells, before rigorous conclusions can be reached.
In vascular smooth muscle cells and in neuroendocrine PC12 cells, a rise in [Ca 2+ ] i appears to be sucient to engage the ERK cascade via growth factor-independent tyrosine phosphorylation of receptor tyrosine kinases (Eguchi et al., 1998; Zwick et al., 1997) . In these cellular settings Pyk2, a focal adhesion kinase related tyrosine kinase independently activated by Ca 2+ and phorbol esters (Lev et al., 1995) , has recently been placed upstream of receptor tyrosine kinases in the signaling pathway from G q/11 -coupled receptors to ERKs (Eguchi et al., 1999; Solto, 1998) . To better understand mitogenic signaling by G q/11 -coupled receptors in SCLC cells, a detailed analysis of the role of receptor tyrosine kinases like c-kit and of non-receptor tyrosine kinases such as Pyk2 should be enlightening in the future.
Dierential eects of substance P-derived broad spectrum antagonists on neuropeptide receptor signaling in Swiss 3T3 cells, a frequently used cellular substitute for SCLC cells, were interpreted to indicate activation of G 12/13 proteins by neuropeptide receptors (Dhanasekaran et al., 1998; Jarpe et al., 1998; Mitchell et al., 1995) . A second line of evidence is provided by the demonstration that G 12/13 proteins signal to the monomeric GTPase Rho, which is involved in the regulation of the cytoskeleton (Buhl et al., 1995) , and that neuropeptides like bombesin regulate Rhomediated stress ®ber formation in Swiss 3T3 cells (Ridley and Hall, 1994) . However, by monitoring receptor-mediated binding of [a-32 P]GTP azidoanilide to G proteins we present the ®rst direct evidence that neuropeptide receptor like GALR2 in fact activate G 12 proteins in SCLC cells. Furthermore, we show that the agonist-bound GALR2 stimulates the formation of Rho-GTP in H69 and H510 cells. The magnitude of the increases in RhoA activation noted by us and by others (Gohla et al., 1998) is usually less than twofold and is similar to the situation when Ras activation by G-protein-coupled receptors is measured.
The search for the causative oncogene of soft tissue sarcoma led to the identi®cation of human Ga 12 as a putative oncogene in NIH3T3 cells (Chan et al., 1993) , and Rho family proteins contribute signi®cantly to the malignant growth properties of Ras-transformed cells (Zohn et al., 1998) . As yet, the relevance of neuropeptide-induced G 12 and Rho activation in SCLC cells is poorly understood. ADP-ribosylation of RhoA in SCLC cells by Clostridium botulinum C3 exoenzyme leads to cadherin-mediated compaction and aggregation of SCLC cells (Tokman et al., 1997) . Thus, Rho proteins control the adhesive properties and probably also the metastatic potential of SCLC cells. The neuropeptide-controlled growth of SCLC cells appears to be controlled by a delicately orchestrated interplay between various signaling pathways initiated by Gprotein-coupled neuropeptide receptors. Overexpression of GTPase-de®cient G-protein a subunits of the G q/11 family, for instance, results in discordant signal transduction and growth inhibition (Heasley et al., 1996) . Likewise, expression of a constitutively active Raf kinase in SCLC cells leads to persistent ERK activation but inhibition of clonogenicity and growth arrest, most probably due to a marked induction of the cyclin-dependent kinase inhibitor p27 kip1 (Ravi et al., 1998) . Simultaneous signaling of neuropeptide receptors to the G q /PLC/Ras/ERK and a still ill-de®ned G 12 /Rho pathway may be required to regulate the expression of cyclin-dependent kinase inhibitors to allow cell cycle progression (Olson et al., 1998) . Thus, the neuropeptide receptor/G 12 /Rho signaling sequence in SCLC cells may oer novel therapeutic targets to interfere with the proliferation of these tumor cells.
Materials and methods
Materials
COS-7, HEK293, and Swiss 3T3 cells were from ATCC (Manassas, Virginia, USA). Cell culture media were obtained from Biochrom, and fetal bovine serum was from Gibco ± BRL. Transferrin, hydrocortisone, selenium, estradiol, insulin, and bovine serum albumin were from Sigma. Pertussis toxin, porcine galanin, GF109203X, and phorbol-12-myristate-13-acetate were obtained from Calbiochem. Texas Red-coupled dextran, BAPTA, AM and fura-2, AM were purchased from Molecular Probes. Antibodies against RhoA, Ga i , and ERK1/2 (Sc-154) were from Santa Cruz Biotechnology. Enzyme-linked secondary antibodies, anti GST-antibody and Protein ASepharose were obtained from Sigma. Cell culture and transfection H69 and H510 cells were routinely cultured in RPMI 1640 with 10% heat-inactivated fetal bovine serum (FBS) without antibiotics in a humidi®ed atmosphere containing 5% CO 2 at 378C. For experimental purposes H69 cells were cultured in HITESA medium (RPMI 1640 supplemented with 10 nM hydrocortisone, 5 mg/ml insulin, 10 mg/ml transferrin, 10 nM estradiol, 30 nM selenium and 0.25% bovine serum albumin) as described (Sethi and Rozengurt, 1991a) . COS-7 cells and Swiss 3T3 cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, and 10% FBS in 7% CO 2 at 378C. HEK293 cells were cultured in essential minimal Eagle's medium (MEM) with Earle's salts containing antibiotics and 10% FBS in a humidi®ed atmosphere containing 5% CO 2 at 378C. For expression purposes, COS-7 cells were cultured in 12-well plates (200 000 cells/well), transfected by a standard calcium-phosphate procedure and analysed 72 h later.
Cloning of GALR2
The cDNA coding for the human type 2 galanin receptor (GALR2) was isolated from H69 cells employing the rapid ampli®cation of cDNA ends technique (RACE), exactly following the procedure described by Frohman et al. (1988) . Brie¯y, 2 mg of total RNA were reverse transcribed using the Q T primer. For 3' RACE, a primer complementary to nucleotides 238 ± 259 of the rat GALR2 cDNA and primer Q O were used. A second PCR reaction was performed with diluted ampli®cation products obtained in the ®rst step using a primer complementary to nucleotides 290 ± 315 of the rat GALR2 and the primer Q I . The resulting PCR product was cloned into the T-easy vector (TA Cloning Kit, Invitrogen) and sequenced with Ampli-Taq DNA Polymerase FS (Perkin Elmer) using an automated DNA sequencer (ABI PRISM 377, Perkin-Elmer).
5' RACE was performed with human brain MarathonReady cDNA and the Advantage-GC cDNA PCR Kit (both Clontech, Heidelberg). A ®rst ampli®cation was performed using 5 ml of human brain cDNA, the supplier's adaptor primer 1, and an antisense primer complementary to the PCR product obtained above (corresponding to nucleotides 385 ± 364 of GALR2 cDNA). A portion of the initial PCR reaction was diluted and ampli®ed with adaptor primer 2 and a second antisense primer (nucleotides 340 ± 319). The PCR product obtained was sequenced and speci®c primers for the 5'-and 3'-end of GALR2 were designed to amplify the fulllength receptor from H69 cell cDNA. The exact sequence of the GALR2 was determined by direct sequencing of three independent ampli®cation products. Individual clones were obtained using the TA Cloning Kit, analysed by sequencing, and a construct harboring the exact GALR2 cDNA was subcloned into the mammalian expression vectors pcDNA3 (Invitrogen) and pcD-PS.
RT ± PCR of galanin receptor subtypes
Total RNA from H69 and H510 cells was isolated with Trizol reagent (Gibco ± BRL) and reverse transcribed (Super-script II, Gibco ± BRL), followed by a digestion with RNase H (Promega) according to the manufacturer's instructions. PCR-reactions were performed with the Advantage-GC cDNA PCR Kit (Clontech, Heidelberg) using sense (S) and antisense (AS) oligonucleotides for the cDNAs of GALR1 (nucleotides 249 ± 268 (S) / 802 ± 821 (AS)), GALR2 (290 ± 315 (S) / 767 ± 788 (AS)), and GALR3 (311 ± 336 (S) / 826 ± 850 (AS)). The cycling parameters for PCR were 30 s at 958C, 45 s at 558C (608C for GALR3), and 2 min at 688C for 40 cycles, with a pre-and post-incubation of 2 min at 958C and 7 min at 688C, respectively. The resulting PCR products were analysed on a 1% agarose gel.
Immunoprecipitation procedure H69 cells were cultured in HITESA for 3 ± 5 days and washed twice in RPMI 1640. Aliquots of approximately 3610 6 cells were incubated in fresh RPMI 1640 for 30 min at 378C and subsequently treated as described. Cells were transferred onto ice and lysed in 500 ml of ice-cold lysis buer (50 mM TrisHCl, 100 mM NaCl, 5 mM EDTA, 1 mM DTT, 40 mM sodium pyrophosphate, 500 M sodium orthovanadate, 1% Triton X-100, 1 mM phenylmethylsulfonyl¯uoride, 1 M leupeptin and 0.1 M aprotinin, pH 7.5) for 15 min. Lysates were cleared by centrifugation at 10 000 g for 15 min at 48C and supernatants were diluted 1 : 1 into lysis buer without Triton X-100. Cleared lysates were then subjected to immunoprecipitation with 2 mg of the appropriate antibody overnight at 48C at constant rotation. Thirty ml of protein ASepharose beads (50%, vol/vol) were added, and lysates were further incubated for 2 h at 48C.
Membrane preparation
H69 and COS-7 cells were washed with phosphate buered saline (PBS), resuspended in mannitol buer (220 mM mannitol, 70 mM sucrose, 5 mM HEPES, 0.5 mM EDTA, pH 7.4) and ruptured by nitrogen cavitation. Nuclei and cellular debris were removed by centrifugation at 600 g for 10 min. Membranes were pelleted by centrifugation at 48C for 30 min at 40 000 g, resuspended in 10 mM triethanolamine HCl (pH 7.4), and stored at 7708C.
Photolabeling of G-protein a subunits
[a 32 P]GTP azidoanilide was synthesized and puri®ed as described (Oermanns et al., 1991) . Photolabeling and immunoprecipitation of membrane G-proteins was performed as described . Brie¯y, cell membranes (100 ± 150 mg) were incubated in the absence or presence of receptor agonist for 3 min (Ga i ), 10 min (Ga s,q ), or 30 min (Ga 12,13 ) with 10 nM [a 32 P]GTP azidoanilide, followed by UV-irradiation at 254 nm for 10 s. Photolabeled G-proteins were solubilized, and insoluble material was removed by centrifugation. Lysates were precleared by addition of protein A-Sepharose beads, and subsequently 10 ml of either antiserum AS 86 (Ga i ), AS 370 (Ga q ), AS 233 (Ga 12 ), or AS 343 (Ga 13 ) was added to the supernatants for immunoprecipitation. The antibodies used were raised against peptides corresponding to speci®c regions of G-protein a subunits and have been described before (Allgeier et al., 1994; Laugwitz et al., 1994) . Immunoprecipitated G-protein a subunits were separated on 10% SDS-polyacrylamide gels and visualized by autoradiography of dried gels with Kodak X-Omat AR-5 ®lms or with a phosphoimaging system (Fuji BAS1000).
Determination of intracellular calcium concentration, inositol phosphate formation and cyclic AMP accumulation
Measurement of the intracellular calcium concentration ([Ca
2+
] i ) was performed as described previously (Sethi and Rozengurt, 1991a) with modi®cations. Brie¯y, 4 ± 6610 6 H69 cells, cultured in HITESA medium for 3 ± 5 days, were washed in RPMI 1640 without fetal bovine serum and incubated for 2 h at 378C in 10 ml of fresh RPMI 1640. Cells were further incubated with 1 mM fura-2, AM for 5 min, centrifuged at 800 g for 15 s and resuspended in 2 ml of a solution containing 140 mM NaCl, 5 mM KCl, 0.9 mM MgCl 2 , 1.8 mM CaCl 2 , 25 mM glucose, 16 mM HEPES, 6 mM Tris, at pH 7.2. The cell suspension was transferred to a cuvette, stirred continuously, and¯uorescence was recorded at 378C in a Perkin-Elmer LS 50 B¯uorescence spectrophotometer with dual wavelength excitation of 340 and 380 nm and an emission wavelength of 510 nm. To remove extracellular Ca 2+ aliquots of 200 mM EGTA were added sequentially (®nal concentration in the cuvette: 3.9 mM) until a stable baseline of the F 340/380 ratio was reached. Lysis of cells at the end of an experiment resulted in a further decline of the F 340/380 ratio demonstrating that Ca 2+ interacting with intracellular fura-2 was chelated by the EGTA present in the incubation buer. Intracellular calcium concentrations were calculated as described (Kao, 1994) .
For the determination of inositol phosphates, cells were transfected with GALR2, cultured for 48 h, and labeled with 2 mCi/ml of myo-[2-3 H]inositol for 20 ± 24 h. Cells were washed twice with serum-free culture medium without antibiotics containing 10 mM LiCl and stimulated with the same medium containing agonists at variable concentrations for 60 min. Reactions were terminated by aspiration of the medium, and cells were lysed in 0.3 ml NaOH (0.1 M) for 5 min, neutralized by addition of 0.2 ml of formic acid (0.2 M), and diluted with 2 ml of a solution consisting of 5 mM Na-borate and 0.5 mM EDTA. Agonist-induced formation of intracellular inositol phosphates was determined by anion-exchange chromatography as described (Berridge, 1983) .
To determine cyclic AMP formation, COS-7 and HEK293 cells were transfected with expression plasmids. Forty-eight hours after transfection, 2 mCi/ml of [2, H]adenine was added to the growth medium. After a labeling period of 20 ± 24 h, cells were washed twice with serum-free culture medium containing 1 mM 3-isobutyl-1-methylxanthine (IBMX, Sigma) and stimulated with appropriate concentrations of agonist for 60 min as indicated. Reactions were terminated by aspiration of the medium and addition of 1 ml of ice-cold 5% trichloroacetic acid containing 1 mM ATP and 1 mM cAMP. Intracellular [ 3 H]cAMP was determined by anion-exchange chromatography as described (Salomon et al., 1974) .
MAP kinase assay
Endogenously expressed ERK1 and ERK2 were immunoprecipitated from H69 cells by incubating cleared lysates with an antibody against ERK1/2 (Sc-154). Immune complexes were pelleted by centrifugation at 5000 g for 2 min and washed three times with lysis buer and two times with kinase buer (40 mM HEPES, 5 mM magnesium acetate, 2 mM DTT, 1 mM EGTA and 200 mM sodium orthovanadate, pH 7.5). Kinase reactions were performed in 50 ml kinase buer containing 250 mg/ml myelin basic protein (MBP, Sigma) and 2 mM protein kinase A inhibitor (fragment 6-22 amide, Sigma). Kinase reactions were started by adding 5 ml of 500 mM ATP containing 2 mCi [g-32 P]ATP, incubated for 20 min at 258C, and stopped with the addition of 6 ml of 88% formic acid. The reaction mixture was spotted onto pieces of Whatman P81 chromatography paper (262 cm), and washed four times with 150 mM phosphoric acid. Radioactivity incorporated into MBP was measured by liquid scintillation counting. Basal counts ranged from 3000 to 7000 c.p.m. The radioactivity of reactions performed without immune-complex was between 150 and 250 c.p.m.
RhoA ELISA
For the assessment of Rho activation, a GST-Rho kinase a (GST-ROK) fusion protein known to bind the GTP-loaded form of RhoA and Cdc42 (Kranenburg et al., 1999) was used. To quantitatively analyse the binding of GST-ROK to GTP-loaded RhoA, an ELISA-based method was established. The GST fusion protein was prepared as previously described (Kranenburg et al., 1999) and stored at 7808C. Protein preparations were stable for up to 2 weeks as determined by anti-GST immunoblotting (data not shown). Ninety-six well plates were coated with 150 ml/well rabbit polyclonal anti-GST antibody (dilution 1 : 100) overnight at 48C. After washing with phosphate buered saline containing 0.1% Triton X-100 (PBST), GST-ROK fusion protein was added (100 ml/well) and incubated for 1 h at room temperature (RT). In parallel, stimulation of cells (2610 6 cells/tube) was carried out at 378C. Cells were lysed in 500 ml ice-cold lysis buer (150 mM NaCl, 50 mM Tris pH 7.4, 5 mM MgCl 2 , 0.1% Triton X-100, 10% glycerol) for 15 min, and insoluble material was removed by centrifugation. After washing plates with PBST, cell lysates were split, added to the 96-well plates (100 ml/well) and incubated for 45 min at 48C. Plates were then washed with PBST, and bound GTP-RhoA was analysed using a monoclonal anti-RhoA antibody (dilution 1 : 400) followed by incubation with a horseradish peroxidaseconjugated anti-mouse IgG antibody. Hydrogen peroxide and o-phenylenediamine (Sigma) (2.5 mM each in 0.1 M phosphate-citrate buer, pH 5.0) were then added to serve as substrate and chromogen, respectively. After a 10 min incubation at RT, the enzymatic reaction was stopped with 1 M H 2 SO 4 containing 0.05 M Na 2 SO 3 , and the color development was assessed bichromatically at 450 and 630 nm with a Titertek Multiscan MCC/340 ELISA reader (Labsystems).
Cytoskeletal reorganization
Quiescent, serum starved Swiss 3T3 cells were grown on glass coverslips with imprinted squares to facilitate the localization of injected cells. Expression plasmids coding for GALR2 and, as negative control, GALR2 D 218 ± 230 were microinjected into the nucleus together with Texas Red-coupled dextran (5 mg/ml) to visualize injected cells. After micro-injection, cells were incubated overnight at 378C, and subsequently stimulated with 100 nM galanin 1 ± 29 for 15 min, ®xed in 4% paraformaldehyde for 20 min, and permeabilized in 0.2% Triton X-100 for 5 min. Actin ®laments were stained with 0.5 mg/ml¯uorescein isothiocyanate (FITC)-phalloidin (Sigma) for 40 min. The coverslips were mounted on microscope slides and visualized on an inverted microscope (Zeiss Axiovert 100).
